“…The results obtained for nalidixic acid (25%), and ciprofloxacin (3.75%) are of concern, because recent studies have detected increases in isolation of Salmonella spp strains resistant to quinolones in Germany (Malorny, Schoroeter, & Helmuth, 1999), England and Wales (Threlfall, Day, Pinna, Charlett, & Goodyear, 2006) and Spain (Marimón, Gomáriz, Zigorraga, Cilla, & Pérez-Trallero, 2004). Recently, the CLSI added a guideline recommending clinical laboratories to routinely test for nalidixic acid resistance in extraintestinal Salmonella isolates to alert physicians of the emerging resistance (Clinical & Laboratory Standards Institute (CLSI/NCCLS), 2004).…”